; and (2) the term State includes the District of Columbia, Puerto Rico, and any commonwealth, territory, enclave, Indian Tribe, or possession of the United States. . III DESIGNATED STATE MEDICAL CANNABIS PRODUCT SAFETY ACT 301. Grandfathering of State medical cannabis products into interstate commerce Subchapter V of chapter 9 of title 21 of the United States Code (the Federal Food, Drug, and Cosmetic Act) is amended by adding at the end the following new part: J DESIGNATED STATE MEDICAL CANNABIS PRODUCTS Sec. 360ggg. Definitions. Sec. 360ggg–1. Regulation of medical cannabis products. Sec. 360ggg–2. Cannabis-infused foods, beverages, and supplements. Sec. 360ggg–3. Cannabis cosmetics. Sec. 360ggg–4. Liability and method of payment. Sec. 360ggg–5. Private right of action and administrative remedy. 360ggg. Definitions In this part: (1) The term designated State medical cannabis product — (A) means an article that is produced by a State and federally licensed or permitted medical cannabis business, pursuant to a State medical cannabis program and contains marihuana , as defined in section 102(16) of the Controlled Substances Act; (B) means any other article that contains either marihuana , as defined in section 102 of the Controlled Substances Act, deemed appropriate by the Secretary, after taking into account any investigational new drug application or investigational new animal drug application for the same medical cannabis product submitted in accordance with regulations applicable to such applications in title 21 of the Code of Federal Regulations, unless any period of exclusivity for a new drug under section 355(c)(3)(E)(ii) of this title or section 355(j)(5)(F)(ii) of this title, or the extension of any such period under section 355a of this title, or any period of exclusivity for a new animal drug under section 360b(c)(2)(F) of this title, applicable to such medical cannabis product has not expired